EPGNF 株価推移チャート
EPGNF 株価予測
Epigenomics AG
$0
0%
$0
終値： Jun 18, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Jun 18, 20:00:00 GMT-4
戻る
Epigenomics AG (EPGNF) 株価予測
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
Epigenomics AGとは何ですか？
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
